Summer time 2026 has produced an uncommon public well being image on the CDC Journey Well being Notices web page: three simultaneous lively journey notices for chikungunya — the mosquito-borne virus identified for inflicting weeks of debilitating joint ache — throughout three completely different geographic areas. Suriname, a rustic on the northeastern coast of South America, has had an lively chikungunya outbreak since February 2026. Mayotte, a French territory within the Indian Ocean off the coast of Mozambique, has been below a CDC chikungunya discover since March 10, 2026. And French Guiana, the French abroad territory on the northern coast of South America adjoining to Brazil, acquired a brand new CDC journey discover for chikungunya on June 4, 2026 — simply 10 days in the past.
Three simultaneous lively outbreaks throughout two continents and the Indian Ocean, all in locations that obtain American vacationers throughout peak summer time season, all involving the identical virus, and all preventable by a vaccine that the majority American vacationers have by no means heard of.
Chikungunya is brought on by the chikungunya alphavirus, transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes — the identical species chargeable for dengue fever and Zika virus transmission. It can not unfold individual to individual. It requires a mosquito chew for transmission, which suggests vacationers who successfully forestall mosquito bites can shield themselves. However not like dengue — for which no reliably efficient, extensively out there vaccine existed within the U.S. till just lately — chikungunya now has an FDA-approved single-dose vaccine that gives broad, sturdy safety.
The Sample of These Three Simultaneous Outbreaks
The geographic distribution of the three present CDC chikungunya notices displays distinct however parallel epidemiological conditions. In Suriname, chikungunya has been circulating since a minimum of February 2026, per the nation’s tropical local weather that helps year-round Aedes mosquito exercise. Suriname borders Guyana to the west, Brazil to the south, and French Guiana to the east — which means outbreak exercise in Suriname creates danger for cross-border unfold to adjoining territories, and the French Guiana discover issued June 4 is probably going related to regional transmission dynamics that started in Suriname and Brazil.
Mayotte’s chikungunya outbreak is separate in origin — the island’s subtropical Indian Ocean local weather creates impartial situations for Aedes exercise, and chikungunya has a well-documented historical past of enormous outbreak cycles in Indian Ocean territories, together with the catastrophic 2005–2006 outbreak in La Réunion that contaminated almost one-third of the island’s inhabitants.
What these three outbreaks share is the presence of Aedes aegypti or Aedes albopictus at epidemic transmission ranges, a inhabitants of prone people with out prior immunity, and the present arrival of the summer time journey season, which will increase the likelihood of importation to the US by way of returning vacationers.
What Chikungunya Does to the Human Physique
The phrase chikungunya comes from the Makonde language of Tanzania, which means “that which bends up” — a reference to the stooped posture that sufferers undertake in response to extreme joint ache. The outline is medically correct and experientially unforgettable. After an incubation interval of two to 12 days following a mosquito chew, sufferers develop sudden excessive fever — typically above 103°F — accompanied by polyarthralgia, the simultaneous extreme painful irritation of a number of joints. The fingers, wrists, ankles, and toes are mostly affected, and the ache is regularly described by sufferers as worse than something they’ve skilled. Many can not stroll, gown, or grip a cup.
The acute section usually lasts 7 to 10 days. Most sufferers recuperate. However roughly 25 to 50 % of individuals contaminated with chikungunya develop continual post-chikungunya arthritis — persistent joint ache that continues for months to years after the preliminary an infection has resolved. That is the longest-lasting and most debilitating consequence of chikungunya, and it disproportionately impacts older adults and people with pre-existing joint illness.
The Vaccine That Vacationers Are Not Getting
The FDA permitted Ixchiq (chikungunya vaccine) in November 2023 for adults 18 and older at elevated danger of chikungunya publicity. Ixchiq is a live-attenuated, single-dose vaccine that requires no booster and has demonstrated sturdy immunogenicity and a suitable security profile in medical trials. It’s out there by way of journey medication clinics and lots of main care suppliers.
Regardless of its approval, Ixchiq stays considerably underutilized amongst American vacationers to chikungunya-endemic and outbreak-affected areas. Consciousness of the vaccine’s existence is low amongst each sufferers and a few basic practitioners who don’t concentrate on journey medication. Vacationers heading to Suriname, French Guiana, Mayotte, or any of the numerous Caribbean and South American locations at the moment experiencing elevated chikungunya exercise ought to particularly ask about Ixchiq at their journey medication session.
The vaccine requires a minimum of 28 days to induce full safety, so vacationers ought to plan accordingly — these departing inside 28 days must be suggested to depend on intensive mosquito chew prevention whereas the vaccine turns into efficient, or might not profit from vaccination for his or her present journey. As with all mosquito-borne illness prevention, repellent use, protecting clothes, air con, and mattress nets stay important enhances to vaccination.
Incessantly Requested Questions
Q: The place are the present chikungunya outbreaks with CDC journey notices?
A: As of June 2026, lively CDC chikungunya journey notices cowl Suriname (February 2026), Mayotte, a French Indian Ocean territory (March 10, 2026), and French Guiana (June 4, 2026).
Q: What are the signs of chikungunya?
A: Sudden excessive fever and extreme polyarthralgia — simultaneous joint ache in a number of joints, particularly the fingers, wrists, ankles, and toes — starting 2 to 12 days after a mosquito chew. The ache is regularly described because the worst the affected person has ever skilled. Most circumstances resolve inside 7 to 10 days, however 25–50% develop continual joint ache lasting months to years.
Q: Is there a vaccine for chikungunya?
A: Sure. Ixchiq is an FDA-approved single-dose live-attenuated vaccine for adults 18 and older. It was permitted November 2023 and is offered at journey medication clinics. It requires roughly 28 days to turn into absolutely efficient.
Q: Who ought to get vaccinated towards chikungunya earlier than journey?
A: Adults 18 and older touring to areas with lively chikungunya transmission who may have out of doors publicity to mosquitoes. This at the moment consists of vacationers to Suriname, French Guiana, Mayotte, and different lively outbreak areas.
Q: How is chikungunya completely different from dengue fever?
A: Each are transmitted by Aedes mosquitoes and trigger fever. Chikungunya is distinguished by the extreme arthralgia (joint ache) that dominates its medical image and may persist for months to years. Dengue extra generally causes a attribute rash, extreme headache, and probably hemorrhagic issues.
